Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men

Sexually Transmitted Diseases

Volumn 36, Issue 8, 2009, Pages 498-500

  Kissinger, Patricia J ^a   Reilly, Kathleen ^a   Taylor, Stephanie N ^b   Leichliter, Jami S ^c   Rosenthal, Susan ^d   Martin, David H ^b  

^a TULANE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; HETEROSEXUAL MALE; HUMAN; MALE; MEDICAL INFORMATION; NEISSERIACEAE INFECTION; PRESCRIPTION; PUBLIC HEALTH SERVICE; URETHRITIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HETEROSEXUALITY; HUMANS; INTERVIEWS AS TOPIC; MALE; MASS SCREENING; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RECURRENCE; SEXUAL PARTNERS; TREATMENT OUTCOME; URETHRITIS; YOUNG ADULT;

EID: 68249138343     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181a4d147     Document Type: Article

References (25)

1. Xia M, Whittington WL, Holmes KK, et al. Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae. J Infect Dis 1995; 171:455-458.
2. Hillis SD, Wasserheit JN. Screening for chlamydia-a key to the prevention of pelvic inflammatory disease [comment]. N Engl J Med 1996; 334:1399-1401.
3. Westrom LV. Sexually transmitted diseases and infertility. Sex Transm Dis 1994; 21(suppl 2):S32-S37.
4. Westrom L. Effect of pelvic inflammatory disease on fertility. Venereology 1995; 8:219-222.
5. Lan J, van den Brule AJ, Hemrika DJ, et al. Chlamydia trachomatis and ectopic pregnancy: Retrospective analysis of salpingectomy specimens, endometrial biopsies, and cervical smears. J Clin Pathol 1995; 48:815-819.
6. Pearlman MD, McNeeley SG. A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections. Obstet Gynecol Surv 1992; 47:448-461.
7. Parks KS, Dixon PB, Richey CM, et al. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24:229-235.
8. Joyner JL, Douglas JM Jr, Foster M, et al. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002; 29:196-200.
9. Fung M, Scott KC, Kent CK, et al. Chlamydia and Gonorrhea Re-infection among Males: A Systematic Review of Data to Evaluate the Need for Re-testing. Sex Transm Infect 2007; 83:304-309.
10. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening [summary for patients in Ann Intern Med 2006; 145:I44; PMID: 17043335]. Ann Intern Med 2006; 145:564-572.
11. Gunn RA, Fitzgerald S, Aral SO. Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible "core" transmitters. Sex Transm Dis 2000; 27:343-349.
12. Ellen JM, Gaydos C, Chung SE, et al. Sex partner selection, social networks, and repeat sexually transmitted infections in young men: a preliminary report. Sex Transm Dis 2006; 33:18-21.
13. Centers for Disease Control P, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006 [erratum appears in MMWR Recomm Rep 2006; 55:997.]. MMWR Recomm Rep 2006; 55(RR-11):1-94.
14. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection [comment]. N Engl J Med 2005; 352:676-685.
15. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. [see comment]. Clin Infect Dis 2005; 41:623-629.
16. Centers for Disease Control and Prevention Male Chlamydia Screening Consultation-Meeting Report. Atlanta, GA March 28-29, 2006 Meeting Report May 22, 2007 http://www.cdc.gov/std/chlamydia/ChlamydiaScreening-males.pdf.
17. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: A randomized controlled trial. Clin Infect Dis 2005; 41:623-629.
18. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin North Am 1990; 74:1339-1352.
19. Kissinger P, Rice J, Farley T, et al. Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol 1999; 149:950-954.
20. Pedersen LN, Podenphant L, Moller JK. Highly discriminative genotyping of Chlamydia trachomatis using omp1 and a set of variable number tandem repeats. Clin Microbiol Infect 2008; 14:644-652.
21. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: A meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29:497-502.
22. Tobin JM, Harindra V, Mani R. Which treatment for genital tract Chlamydia trachomatis infection? Int J STD AIDS 2004; 15:737-739.
23. Wang SA, Papp JR, Stamm WE, et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 2005; 191:917-923.
24. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995; 20(suppl 1):S47-S65.
25. Stamm WE, Batteiger BE, McCormack WM, et al. A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. Sex Transm Dis 2007; 34:545-552.